Multilocus Inherited Neoplasia Alleles Syndrome
Open Access
- 1 March 2016
- journal article
- case report
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 2 (3) , 373-379
Abstract
Mendelian causes of inherited cancer susceptibility are mostly rare and characterized by variable expression and incomplete penetrance. Phenotypic variability may result from a range of causes including locus heterogeneity, allelic heterogeneity, genetic and environmental modifier effects, or chance. Another potential cause is the presence of 2 or more inherited cancer predisposition alleles in the same individual. Although the frequency of such occurrences might be predicted to be low, such cases have probably been underascertained because standard clinical practice has been to test candidate inherited cancer genes sequentially until a pathogenic mutation is detected. However, recent advances in next-generation sequencing technologies now provide the opportunity to perform simultaneous parallel testing of large numbers of inherited cancer genes. Herein we provide examples of patients who harbor pathogenic mutations in multiple inherited cancer genes and review previously published examples to illustrate the complex genotype-phenotype relationships in these cases. We suggest that clinicians should proactively consider the likelihood of this phenomenon (referred to herein as multilocus inherited neoplasia alleles syndrome [MINAS]) in patients with unusual inherited cancer syndrome phenotypes. To facilitate the clinical management of novel cases of MINAS, we have established a database to collect information on what is likely to be an increasingly recognized cohort of such individuals.Keywords
This publication has 57 references indexed in Scilit:
- Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: Report from the constitutional mismatch repair deficiency consortiumEuropean Journal of Cancer, 2014
- Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical managementBreast Cancer Research and Treatment, 2012
- Two double heterozygotes in a South African Afrikaner family: implications for BRCA1 and BRCA2 predictive testingClinical Genetics, 2012
- What Three Wise Men have to say about diagnosisBMJ, 2011
- Two patients with germline mutations in both BRCA1 and BRCA2 discovered unintentionally: a case series and discussion of BRCA testing modalitiesBreast Cancer Research and Treatment, 2011
- Double Heterozygotes for Non-Caucasian Families with Mutations in BRCA-1 and BRCA-2 GenesThe Breast Journal, 2006
- Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutationsJournal of Medical Genetics, 2005
- A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genesJournal of Medical Genetics, 2002
- An unaffected individual from a breast/ovarian cancer family with germline mutations in both BRCA1 and BRCA2Clinical Genetics, 2000
- A Breast Cancer Patient of Scottish Descent with Germ-Line Mutations in BRCA1 and BRCA2The American Journal of Human Genetics, 1998